Recombinant spider silk functionalized with a CD40 agonist shows improved capability to activate human B cells in vitro - A novel module for cancer immunotherapy.
- DOI
- 10.1016/j.ijbiomac.2025.147503
- Published
- 2025-09-06
- Container
- Int J Biol Macromol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijbiomac.2025.147503,
title = {Recombinant spider silk functionalized with a CD40 agonist shows improved capability to activate human B cells in vitro - A novel module for cancer immunotherapy.},
author = {Keller G and Widhe M and Jansson R and Vaisbourd E and Pires RS and Hedhammar M.},
year = {2025},
journal = {Int J Biol Macromol},
doi = {10.1016/j.ijbiomac.2025.147503},
url = {https://doi.org/10.1016/j.ijbiomac.2025.147503}
}RIS
TY - JOUR TI - Recombinant spider silk functionalized with a CD40 agonist shows improved capability to activate human B cells in vitro - A novel module for cancer immunotherapy. AU - Keller G AU - Widhe M AU - Jansson R AU - Vaisbourd E AU - Pires RS AU - Hedhammar M. PY - 2025 JO - Int J Biol Macromol DO - 10.1016/j.ijbiomac.2025.147503 UR - https://doi.org/10.1016/j.ijbiomac.2025.147503 ER -
APA
G, K., M, W., R, J., E, V., RS, P., & M., H. (2025). Recombinant spider silk functionalized with a CD40 agonist shows improved capability to activate human B cells in vitro - A novel module for cancer immunotherapy.. Int J Biol Macromol. https://doi.org/10.1016/j.ijbiomac.2025.147503
Source records
- europe-pmc · retrieved 2026-09-26T18:22:35.273Z